Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q8TEA1
UPID:
NSUN6_HUMAN
Alternative names:
NOL1/NOP2/Sun and PUA domain-containing protein 1; NOL1/NOP2/Sun domain family member 6
Alternative UPACC:
Q8TEA1; B0YJ54
Background:
tRNA (cytosine(72)-C(5))-methyltransferase NSUN6, also known as NOL1/NOP2/Sun and PUA domain-containing protein 1 or NOL1/NOP2/Sun domain family member 6, is a specialized enzyme. It plays a crucial role in the post-transcriptional modification of tRNA by specifically methylating the C5 position of cytosine 72 in tRNA(Thr)(TGT) and tRNA(Cys)(GCA). This methylation process is essential for the proper folding and function of tRNA molecules, influencing protein synthesis and cellular health.
Therapeutic significance:
Understanding the role of tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 could open doors to potential therapeutic strategies. Its precise function in tRNA modification suggests a foundational role in protein synthesis, offering a novel angle for targeting diseases at the molecular level.